HEADER TRANSFERASE/INHIBITOR 03-APR-20 6WF5 TITLE CRYSTAL STRUCTURE OF HUMAN NAA50 IN COMPLEX WITH A TRUNCATED COFACTOR TITLE 2 DERIVED INHIBITOR (COMPOUND 2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: N-ALPHA-ACETYLTRANSFERASE 50; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HNAA50P,N-ACETYLTRANSFERASE 13,N-ACETYLTRANSFERASE 5,HNAT5, COMPND 5 N-ACETYLTRANSFERASE SAN HOMOLOG,HSAN,N-EPSILON-ACETYLTRANSFERASE 50, COMPND 6 NATE CATALYTIC SUBUNIT, NAA50; COMPND 7 EC: 2.3.1.258,2.3.1.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ACE-MET-LEU-GLY-PRO-NH2; COMPND 11 CHAIN: C, D; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NAA50, MAK3, NAT13, NAT5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS N-ALPHA-ACETYLTRANSFERASE 50, INHIBITOR COMPLEX, TRANSFERASE, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,J.FENG,Y.-L.DENG,A.E.STEWART REVDAT 3 23-OCT-24 6WF5 1 REMARK REVDAT 2 18-OCT-23 6WF5 1 REMARK REVDAT 1 01-JUL-20 6WF5 0 JRNL AUTH P.P.KUNG,P.BINGHAM,B.J.BURKE,Q.CHEN,X.CHENG,Y.L.DENG,D.DOU, JRNL AUTH 2 J.FENG,G.M.GALLEGO,M.R.GEHRING,S.K.GRANT,S.GREASLEY, JRNL AUTH 3 A.R.HARRIS,K.A.MAEGLEY,J.MEIER,X.MENG,J.L.MONTANO, JRNL AUTH 4 B.A.MORGAN,B.S.NAUGHTON,P.B.PALDE,T.A.PAUL,P.RICHARDSON, JRNL AUTH 5 S.SAKATA,A.SHAGINIAN,W.K.SONNENBURG,C.SUBRAMANYAM, JRNL AUTH 6 S.TIMOFEEVSKI,J.WAN,W.YAN,A.E.STEWART JRNL TITL CHARACTERIZATION OF SPECIFICN-ALPHA-ACETYLTRANSFERASE 50 JRNL TITL 2 (NAA50) INHIBITORS IDENTIFIED USING A DNA ENCODED LIBRARY. JRNL REF ACS MED.CHEM.LETT. V. 11 1175 2020 JRNL REFN ISSN 1948-5875 JRNL PMID 32550998 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00029 REMARK 2 REMARK 2 RESOLUTION. 2.04 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.04 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 21219 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.820 REMARK 3 FREE R VALUE TEST SET COUNT : 1023 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.04 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.14 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.55 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2761 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2470 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2619 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE : 0.2920 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.14 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 142 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2683 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -16.70480 REMARK 3 B22 (A**2) : 5.54960 REMARK 3 B33 (A**2) : 11.15520 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -6.55800 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.237 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.201 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.241 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.204 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.879 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.846 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2766 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3730 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 960 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 76 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 392 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2766 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 345 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3152 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.97 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6WF5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-APR-20. REMARK 100 THE DEPOSITION ID IS D_1000248125. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21247 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.040 REMARK 200 RESOLUTION RANGE LOW (A) : 63.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.72300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 6WF3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CO-CRYSTALLIZATION: NAA50 APO PROTEIN REMARK 280 (14.3 MG/ML) WAS INCUBATED WITH COMPOUND 2 IN A 1:3 MOLAR RATIO REMARK 280 ON ICE FOR 60 MIN. RESERVOIR SOLUTION CONTAINING 0.2 M AMMONIUM REMARK 280 SULFATE AND 30% (W/V) PEG 3K/4K WAS MIXED 1:1 WITH PROTEIN: REMARK 280 LIGAND COMPLEX, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 286.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 26.16950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 GLY B 3 REMARK 465 SER B 4 REMARK 465 SER B 158 REMARK 465 GLY B 159 REMARK 465 GLN B 160 REMARK 465 ASN B 161 REMARK 465 ALA B 162 REMARK 465 ASP B 163 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG B 141 CD NE CZ NH1 NH2 REMARK 470 LYS B 155 CG CD CE NZ REMARK 470 GLN B 165 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 141 -36.84 67.92 REMARK 500 LYS B 140 -79.98 -54.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY D 4 PRO D 5 -33.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE C 1 and MET C 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO C 5 and NH2 C 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues U44 C 101 and ACE C 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE G 1 and MET G 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide PRO G 5 and NH2 G 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues U44 G 101 and ACE G 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6WF3 RELATED DB: PDB DBREF 6WF5 A 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WF5 B 1 169 UNP Q9GZZ1 NAA50_HUMAN 1 169 DBREF 6WF5 C 1 6 PDB 6WF5 6WF5 1 6 DBREF 6WF5 D 1 6 PDB 6WF5 6WF5 1 6 SEQADV 6WF5 GLY A -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF5 SER A 0 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF5 GLY B -1 UNP Q9GZZ1 EXPRESSION TAG SEQADV 6WF5 SER B 0 UNP Q9GZZ1 EXPRESSION TAG SEQRES 1 A 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 A 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 A 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 A 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 A 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 A 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 A 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 A 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 A 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 A 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 A 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 A 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 A 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 A 171 ASP ASN SEQRES 1 B 171 GLY SER MET LYS GLY SER ARG ILE GLU LEU GLY ASP VAL SEQRES 2 B 171 THR PRO HIS ASN ILE LYS GLN LEU LYS ARG LEU ASN GLN SEQRES 3 B 171 VAL ILE PHE PRO VAL SER TYR ASN ASP LYS PHE TYR LYS SEQRES 4 B 171 ASP VAL LEU GLU VAL GLY GLU LEU ALA LYS LEU ALA TYR SEQRES 5 B 171 PHE ASN ASP ILE ALA VAL GLY ALA VAL CYS CYS ARG VAL SEQRES 6 B 171 ASP HIS SER GLN ASN GLN LYS ARG LEU TYR ILE MET THR SEQRES 7 B 171 LEU GLY CYS LEU ALA PRO TYR ARG ARG LEU GLY ILE GLY SEQRES 8 B 171 THR LYS MET LEU ASN HIS VAL LEU ASN ILE CYS GLU LYS SEQRES 9 B 171 ASP GLY THR PHE ASP ASN ILE TYR LEU HIS VAL GLN ILE SEQRES 10 B 171 SER ASN GLU SER ALA ILE ASP PHE TYR ARG LYS PHE GLY SEQRES 11 B 171 PHE GLU ILE ILE GLU THR LYS LYS ASN TYR TYR LYS ARG SEQRES 12 B 171 ILE GLU PRO ALA ASP ALA HIS VAL LEU GLN LYS ASN LEU SEQRES 13 B 171 LYS VAL PRO SER GLY GLN ASN ALA ASP VAL GLN LYS THR SEQRES 14 B 171 ASP ASN SEQRES 1 C 6 ACE MET LEU GLY PRO NH2 SEQRES 1 D 6 ACE MET LEU GLY PRO NH2 HET ACE C 1 3 HET NH2 C 6 1 HET ACE D 1 3 HET NH2 D 6 1 HET U44 C 101 17 HET U44 D 101 17 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP HETNAM U44 (2R)-2-HYDROXY-3,3-DIMETHYL-N-{3-OXO-3-[(2- HETNAM 2 U44 SULFANYLETHYL)AMINO]PROPYL}BUTANAMIDE FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 NH2 2(H2 N) FORMUL 5 U44 2(C11 H22 N2 O3 S) FORMUL 7 HOH *98(H2 O) HELIX 1 AA1 ASN A 15 PHE A 27 1 13 HELIX 2 AA2 ASN A 32 LEU A 40 1 9 HELIX 3 AA3 GLU A 41 GLU A 44 5 4 HELIX 4 AA4 HIS A 65 GLN A 69 5 5 HELIX 5 AA5 ALA A 81 ARG A 84 5 4 HELIX 6 AA6 GLY A 87 GLY A 104 1 18 HELIX 7 AA7 ASN A 117 LYS A 126 1 10 HELIX 8 AA8 ASN A 161 GLN A 165 5 5 HELIX 9 AA9 ASN B 15 PHE B 27 1 13 HELIX 10 AB1 ASN B 32 LEU B 40 1 9 HELIX 11 AB2 VAL B 42 GLU B 44 5 3 HELIX 12 AB3 HIS B 65 GLN B 69 5 5 HELIX 13 AB4 ALA B 81 ARG B 84 5 4 HELIX 14 AB5 GLY B 87 GLY B 104 1 18 HELIX 15 AB6 ASN B 117 LYS B 126 1 10 SHEET 1 AA1 7 ILE A 6 ASP A 10 0 SHEET 2 AA1 7 ALA A 46 PHE A 51 -1 O LEU A 48 N GLY A 9 SHEET 3 AA1 7 ILE A 54 ASP A 64 -1 O GLY A 57 N ALA A 49 SHEET 4 AA1 7 ARG A 71 CYS A 79 -1 O ARG A 71 N ASP A 64 SHEET 5 AA1 7 ASN A 108 GLN A 114 1 O TYR A 110 N LEU A 72 SHEET 6 AA1 7 ALA A 147 ASN A 153 -1 O HIS A 148 N VAL A 113 SHEET 7 AA1 7 GLU A 130 LYS A 135 -1 N LYS A 135 O ALA A 147 SHEET 1 AA2 7 ILE B 6 ASP B 10 0 SHEET 2 AA2 7 ALA B 46 PHE B 51 -1 O LEU B 48 N GLY B 9 SHEET 3 AA2 7 ILE B 54 ASP B 64 -1 O GLY B 57 N ALA B 49 SHEET 4 AA2 7 ARG B 71 CYS B 79 -1 O ARG B 71 N ASP B 64 SHEET 5 AA2 7 ASN B 108 GLN B 114 1 O TYR B 110 N ILE B 74 SHEET 6 AA2 7 ALA B 147 ASN B 153 -1 O HIS B 148 N VAL B 113 SHEET 7 AA2 7 GLU B 130 LYS B 135 -1 N GLU B 133 O VAL B 149 LINK C ACE C 1 N MET C 2 1555 1555 1.38 LINK CH3 ACE C 1 S2 U44 C 101 1555 1555 1.81 LINK C PRO C 5 N NH2 C 6 1555 1555 1.38 LINK C ACE D 1 N MET D 2 1555 1555 1.38 LINK CH3 ACE D 1 S2 U44 D 101 1555 1555 1.81 LINK C PRO D 5 N NH2 D 6 1555 1555 1.38 CISPEP 1 GLU A 143 PRO A 144 0 0.72 CISPEP 2 GLU B 143 PRO B 144 0 -0.96 CISPEP 3 GLY C 4 PRO C 5 0 -25.06 SITE 1 AC1 14 PHE A 27 PRO A 28 TYR A 31 MET A 75 SITE 2 AC1 14 THR A 76 LEU A 77 LEU A 111 HIS A 112 SITE 3 AC1 14 GLN A 114 TYR A 139 HOH A 207 LEU C 3 SITE 4 AC1 14 GLY C 4 U44 C 101 SITE 1 AC2 5 VAL A 29 TYR A 138 LYS A 140 ASP A 163 SITE 2 AC2 5 GLY C 4 SITE 1 AC3 15 PHE A 27 MET A 75 THR A 76 LEU A 77 SITE 2 AC3 15 GLY A 78 CYS A 79 ARG A 84 LEU A 111 SITE 3 AC3 15 HIS A 112 ASN A 117 PHE A 123 TYR A 124 SITE 4 AC3 15 HOH A 231 MET C 2 HOH C 201 SITE 1 AC4 12 PHE B 27 PRO B 28 TYR B 31 MET B 75 SITE 2 AC4 12 THR B 76 LEU B 77 LEU B 111 HIS B 112 SITE 3 AC4 12 TYR B 139 LEU D 3 GLY D 4 U44 D 101 SITE 1 AC5 2 TYR B 138 GLY D 4 SITE 1 AC6 14 PHE B 27 MET B 75 THR B 76 LEU B 77 SITE 2 AC6 14 GLY B 78 CYS B 79 ARG B 84 LEU B 111 SITE 3 AC6 14 HIS B 112 ASN B 117 SER B 119 PHE B 123 SITE 4 AC6 14 TYR B 124 MET D 2 CRYST1 50.937 52.339 64.123 90.00 97.38 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019632 0.000000 0.002543 0.00000 SCALE2 0.000000 0.019106 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015725 0.00000